Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
4 May 2015 |
Main ID: |
NCT01448759 |
Date of registration:
|
06/10/2011 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Evaluation of Plasma Alcohol Concentration in Patients Receiving Paclitaxel or Docetaxel
ALCOOTAX |
Scientific title:
|
Prospective Evaluation of Plasma Alcohol Concentration in Patients Receiving Paclitaxel or Docetaxel Infusion |
Date of first enrolment:
|
October 2011 |
Target sample size:
|
30 |
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT01448759 |
Study type:
|
Interventional |
Study design:
|
Intervention Model: Single Group Assignment, Masking: Open Label
|
Phase:
|
N/A
|
|
Countries of recruitment
|
France
| | | | | | | |
Contacts
|
Name:
|
LE TOURNEAU Christophe, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Institut Curie |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Chemotherapy with docetaxel or paclitaxel on an every 3-week schedule.
- Patient with bitherapy are eligible only if the taxane is the first infusion.
- All type of tumor.
- Age>18 years old.
- Signed written informed consent.
Exclusion Criteria:
- Patient under 18.
- Patient with bitherapy, if docetaxel or paclitaxel is not administered first.
- Patient deprived of liberty.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Tumors
|
Intervention(s)
|
Other: blood sampling
|
Primary Outcome(s)
|
Evaluation of plasma alcohol
[Time Frame: One year]
|
Secondary ID(s)
|
IC 2011-03
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|